# Local Infusion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/local-infusion

- Industry: Healthcare Specialists
- Headquarters: Nashville, US
- Website: www.mylocalinfusion.com
- Total disclosed funding: $44M
- Latest round: Series B (Jun 18, 2025)
- Investors on record: 4

## About

Founded in 2021, and based in Tennessee, US, Local Infusion Inc. operates as a provider of healthcare services for customers in need of therapy or treatment for arthritis, asthma, migraine, and other health conditions. In November 2022, Local Infusion raised USD 4 million in seed funding co-led by new investors Brand Foundry Ventures, and Meridian Street Capital. The firm offers services from centers in New Hampshire and Maine. 

Local Infusion is a tech-enabled ambulatory infusion center (AIC) startup that provides infusion care to patients suffering from autoimmune diseases such as arthritis, spondylitis, asthma, dermatitis, chronic kidney diseases, neurological diseases, and a variety of other diseases with therapies such as actemra, benlysta, Boniva, cimzia, cinqair, dupixent, ilumya, etc.

## Funding rounds

- Series B, Jun 18, 2025, $30M — Transformation Capital
- Series A, Nov 28, 2023, $10M — blisce/, Meridian Street Capital
- Seed, Nov 9, 2022, $4M — Brand Foundry Ventures, Meridian Street Capital

## Investors

- Brand Foundry Ventures (https://capitalatlas.ai/funds/brand-foundry-ventures) — Seed
- Meridian Street Capital (https://capitalatlas.ai/funds/meridian-street-capital) — Seed, Series A
- blisce/ (https://capitalatlas.ai/funds/blisce) — Series A
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series B